Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis [Phase 2]
Phase 2 trial investigating safety, tolerability, efficacy, and dose-response of GSK2831781 in ulcerative colitis has terminated with posted…
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial compares Budesonide Multimatrix (MMX) with Prednisolone for managing mild to moderate ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: Probiotic Treatment of Ulcerative Colitis With Trichuris Suis Ova (TSO) [Phase 2]
Phase 2 clinical trial update on probiotic treatment using Trichuris suis ova (TSO) for ulcerative colitis, completed.
-
CLINICAL_TRIALS trial_result · 2022-03-21Clinical Trial Update: Efficacy and Safety of BBT-401-1S in Ulcerative Colitis [Phase 2]
Phase 2 trial of BBT-401-1S in ulcerative colitis was terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-03-14Clinical Trial Update: Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization [Phase 2]
Phase 2 trial updating golimumab in ulcerative colitis patients with loss of response followed by dose optimization has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-02-28Clinical Trial Update: An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) [Phase 3]
This Phase 3 induction study (LUCENT 1) evaluated mirikizumab in moderately to severely active ulcerative colitis; the trial has completed a…
-
CLINICAL_TRIALS trial_result · 2022-02-21Clinical Trial Update: To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)
Clinical trial update for Remsima in Crohn's disease and ulcerative colitis; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis [Phase 3]
Phase 3 trial update on ontamalimab as maintenance therapy for moderate-to-severe ulcerative colitis; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: Safety and Efficacy of PBF-677 in Ulcerative Colitis Patients [Phase 2]
Phase 2 trial update on PBF-677 for ulcerative colitis reports safety and efficacy findings.
-
CLINICAL_TRIALS trial_result · 2021-12-28Clinical Trial Update: Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission. [Phase 2]
Phase 2 trial of PF-06687234 as add-on to infliximab in active ulcerative colitis (not in remission) was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-12-14Clinical Trial Update: Study of Cimzia for the Treatment of Ulcerative Colitis [Phase 2]
Phase 2 trial update for Cimzia in ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-26Clinical Trial Update: A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]
Phase 3 trial update evaluating the efficacy and safety of Upadacitinib (ABT-494) in moderately to severely active ulcerative colitis comple…
-
CLINICAL_TRIALS trial_result · 2021-11-26Clinical Trial Update: Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis [Phase 2]
Extension study results for APD334-003 in moderately to severely active ulcerative colitis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-11Clinical Trial Update: Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis [Phase 4]
Phase 4 trial updating intravenous dose optimization of vedolizumab in ulcerative colitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current Therapy [Phase 2]
A Phase 2 study evaluated whether adding BI 655130 to patients' TNF inhibitor therapy improves bowel inflammation in mild to moderate ulcera…
-
CLINICAL_TRIALS trial_result · 2021-10-01Clinical Trial Update: Faecal Bacteriotherapy for Ulcerative Colitis [Phase 2]
Phase 2 trial update on faecal bacteriotherapy for ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2021-10-01Clinical Trial Update: Curcumin in Pediatric Ulcerative Colitis [Phase 3]
Phase 3 trial of curcumin in pediatric ulcerative colitis was withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-09-17Clinical Trial Update: Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis [Phase 3]
Phase 3 long-term study update for CP-690,550 in ulcerative colitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-14Clinical Trial Update: Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC) [Phase 3]
Phase 3 trial update on mesalamine 2 g sachet for maintaining remission in ulcerative colitis; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-09-01Clinical Trial Update: Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis [Phase 3]
Phase 3 trial assessing safety and efficacy of RPC1063 in moderate to severe ulcerative colitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-26Clinical Trial Update: Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis). [Phase 3]
Phase 3 trial comparing combination corticosteroids with 5-aminosalicylic acids versus corticosteroids alone for ulcerative colitis has comp…
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors [Phase 3]
Phase 3 study comparing etrolizumab to infliximab in adults with moderate to severe ulcerative colitis who did not receive TNF inhibitors; t…
-
CLINICAL_TRIALS trial_result · 2021-08-05Clinical Trial Update: Ultra-proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease [Phase 4]
Phase 4 trial update on proactive therapeutic drug monitoring in inflammatory bowel disease has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-21Clinical Trial Update: Additive Effect of Probiotics (Mutaflor®) in Patients With Ulcerative Colitis on 5-ASA Treatment. [Phase 4]
Phase 4 clinical trial assessing the additive effect of Mutaflor probiotic in patients with Ulcerative Colitis on 5-ASA therapy has complete…
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases [Phase 2]
Phase 2 clinical trial evaluating low-dose IL-2 to induce regulatory T cells in various autoimmune and inflammatory diseases; trial complete…